Navigation Links
SRI International receives $100,000 Grand Challenges Explorations grant
Date:5/6/2009

MENLO PARK, Calif. May 6, 2008 SRI International announced today that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Krishna Kodukula, Ph.D., executive director of SRI International's Center for Advanced Drug Research (CADRE) in Shenandoah Valley, Virginia and Amit Galande, Ph.D., associate director of Proteomics and Protein Biochemistry at CADRE, titled "Combating Antibiotic Resistance in Tuberculosis."

SRI's project is one of 81 grants announced by the Gates Foundation in the second funding round of Grand Challenges Explorations, an initiative to help scientists around the world explore bold and largely unproven ways to improve health in developing countries. The grants were provided to scientists in 17 countries on six continents, selected from more than 3,000 proposals received by the Foundation in this highly competitive round of funding.

To receive funding, Kodukula and Galande showed in a two-page application how their idea falls outside current scientific paradigms and might lead to significant advances in global health. SRI's research project will address the problem of antibiotic resistance and the need for broad-spectrum antibiotics. Resistant strains of tuberculosis will initially be screened. Based on those results, the project will be expanded to include other pathogenic bacteria that can lead to the development of the next generation of antibiotics.

Since proteins that are antibiotic targets are prone to mutations that can result in antibiotic resistance, researchers will target non-protein components of cells. Small organic molecule metabolites that are essential for the growth and survival of pathogenic bacteria will be used as targets for antibiotic discovery.

"Antibiotic resistance is a serious public health problem around the world," said Dr. Kodukula. "It can change the course of infections that are treatable and lead to diseases that are difficult to cure. Drug resistant strains of tuberculosis pose a grave threat to global health because treatment options are becoming severely limited."

"The winners of these grants are doing truly exciting and innovative work," said Dr. Tachi Yamada, president of the Gates Foundation's Global Health Program. "I'm optimistic that some of these exploratory projects will lead to life-saving breakthroughs for people in the world's poorest countries."


'/>"/>

Contact: Dina Basin
dina.basin@sri.com
650-859-3845
SRI International
Source:Eurekalert

Related biology news :

1. International team finds key gene that allows plants to survive drought
2. BIO-key(R) International Showcasing Biometric Identification Technology at 2009 RSA Conference
3. Canadian biomedical engineering pioneer receives international award
4. Major international study challenges notions of how genes are controlled in mammals
5. International honor for University of East Anglia ocean researcher
6. Biomedical researchers invited to design experiments for the International Space Station
7. International climate change researchers meet, review latest findings
8. International prize for Nottingham spine research
9. Uvalde Center water research could have national, international applications
10. Anatomical Science International joins Springers publishing program
11. UABs Lisa Guay-Woodford earns top international nephrology prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition ... to their offering. ... The report provides separate comprehensive analytics for the US, ... of World. Annual estimates and forecasts are provided for the period ... these markets. Market data and analytics are derived from primary and ...
(Date:2/17/2017)...  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today presented ... drug candidates, PTG-100 and PTG-200, at the 12 ... Colitis Organization (ECCO).  The ECCO congress is being ... from February 15 – 18, 2017. ... drug candidates PTG-100 and PTG-200. PTG-100, a potential ...
(Date:2/16/2017)... PALM BEACH, Fla. , Feb. 16, 2017 ... diagnostics company revolutionizing the development of liquid biopsy ... it has entered into an exclusive license agreement ... will distribute MDNA,s proprietary liquid biopsy test for ... South Korea . This is ...
(Date:2/16/2017)... BEACH, Florida , February 16, 2017 /PRNewswire/ ... improving with the infusion of innovative telemedicine application, ... monitoring services that are experiencing a boom worldwide. ... with the advancement of technologies, services and new ... Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. ...
Breaking Biology Technology: